SCHEDULE: Jorey Chernett Discloses 7.88% Stake in CalciMedica

Jorey Chernett has reported beneficial ownership of 7.88% of CalciMedica, Inc.'s common stock as of November 24, 2025.

Summary

• Jorey Chernett beneficially owns 1,134,847 shares of CalciMedica, Inc. common stock.
• This represents 7.88% of CalciMedica, Inc.'s outstanding common stock.
• Chernett holds sole voting power and sole dispositive power over all 1,134,847 shares.
• The shares were not acquired and are not held for the purpose of changing or influencing the control of CalciMedica, Inc., other than activities solely in connection with a nomination under Rule 240.14a-11.

Sentiment

Score: 6

Explanation: The filing is neutral in its direct content as a regulatory disclosure, but the establishment of a significant individual stake can be perceived as a moderately positive signal of investor confidence, without providing specific financial or operational updates.

Positives

• A significant individual stake of 7.88% by Jorey Chernett could signal confidence in CalciMedica, Inc.'s future prospects and long-term value.

Negatives

• No specific negative information is disclosed in this Schedule 13G filing.

Risks

• No specific risks are mentioned in this Schedule 13G filing.

Future Outlook

This filing does not provide forward-looking statements or guidance regarding CalciMedica, Inc.'s future performance or strategic direction.

Industry Context

Significant ownership disclosures like this Schedule 13G provide transparency into major shareholder positions, which can be a factor in assessing a company's stability and investor confidence within the biotechnology or pharmaceutical industry. Such filings are routine for investors acquiring more than 5% of a company's stock.

Stakeholder Impact

• Shareholders: Provides increased transparency regarding a significant individual investor's stake in the company.
• Management: Indicates the presence of a substantial shareholder who may have an interest in corporate governance, potentially including future nominations to the board.

Key Dates

Recommendation

This Schedule 13G filing primarily discloses a significant ownership stake by an individual. While a substantial stake can be a positive indicator of investor confidence, it does not provide sufficient operational or financial data to warrant a 'buy' or 'sell' recommendation. Investors should 'hold' and await further financial disclosures or strategic updates from CalciMedica, Inc. to make a more informed decision.

Keywords

CalciMedica Inc, Jorey Chernett, Schedule 13G, Beneficial Ownership, Common Stock, Shareholder Stake, SEC Filing